Prenetics is an innovative biotechnology company dedicated to precision medicine in Hong Kong. The self-developed iGenes pharmacogenomics test can collect patient oral cell samples, predict drug response according to individual genetic differences, and help doctors to prescribe the most appropriate drugs to patients with dosage. The company recently merged with New World Zheng Zhigang’s SPAC and was listed on Nasdaq with the stock code PRE.
This article is reproduced from: https://www.itjuzi.com/investevent/13229196
This site is for inclusion only, and the copyright belongs to the original author.